Study shows starving cancer cells of key nutrient slows tumour growth

December 18, 2012, Cancer Research UK
Study shows starving cancer cells of key nutrient slows tumour growth

Depriving cancer cells of a key amino acid dramatically cuts their ability to grow and multiply, according to a new Cancer Research UK study published in Nature.

Scientists at Cancer Research UK's Beatson Institute looked at how cancer cells are able to survive and continue growing when starved of the amino acid serine. Cells are normally able to make serine themselves, but the team at the Beatson found that tumours lacking the p53 protein – which is faulty in at least half of all cancers – could not adapt to this switch and so grew at a much slower rate.

The p53 protein was first discovered by Cancer Research UK scientists and is often referred to as the 'guardian of the genome' as it halts the growth of damaged cells, activates or triggers .

The findings suggest that by targeting the ways which cancer cells use to generate the energy and needed to grow, new approaches to treat cancers could be developed.

Dr Oliver Maddocks, lead researcher based at Cancer Research UK's Beatson Institute, said: "We know that the blocks the growth of cancer cells, but we are increasingly aware that p53 has a 'split personality'. When cells are starved of key nutrients p53 helps them adapt, and could be helping cancer cells survive.  

"Gaining insights of this interplay between cell metabolism and p53 may help us to identify new ways to treat cancer. Reducing the availability of serine to cancer cells, particularly those lacking p53, is a promising new concept, but we're still a long way from knowing whether this could work in patients."

Cancer cells take up large amounts of serine and use it as a building block to quickly grow and generate new cells. This research builds on previous work at the Beatson Institute that found that levels of serine in cancer cells controls a key step in .

Professor Nic Jones, Cancer Research UK's chief scientist, said: "This work shows how we're still learning more about the role p53 can play in cancer, 30 years on from its discovery by Cancer Research UK scientists.

"Understanding how are able to generate the extra energy and molecular building blocks to grow rapidly is becoming an important area of research. Disrupting could lead to a whole new arsenal of drugs to treat cancer and Cancer Research UK scientists are at the forefront of this research."  

Explore further: Scientists discover nucleoli damage could kill cancer cells

More information: Maddocks O.D.K., Berkers C.R., Mason S.M., Zheng L., Blyth K., Gottlieb E. & Vousden K.H. (2012). Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells, Nature, DOI: 10.1038/nature11743

Related Stories

Scientists discover nucleoli damage could kill cancer cells

November 8, 2011
(Medical Xpress) -- Damaging a cell’s nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute ...

New drug shrinks cancer in animals, study shows

April 6, 2011
A study led by researchers at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.

Recommended for you

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.